Uteron Pharma SA

Liège Airport Business Park Liège Airport-Cargo Nord Rue Saint Exupéry 17,
Grâce-Hollogne, 4460
32 4 220 96 30

Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.

Uteron Pharma SA was acquired by Watson Pharmaceuticals on January 23, 2013.

Join Mergr to view all 187 acquisitions of medical products companies in 2013, including 26 acquisitions by private equity firms, and 161 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2013. The largest medical products acquisition in 2013 was Bausch & Lomb - which was acquired by Valeant Pharmaceuticals International for $8.7B.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Uteron Pharma SA.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.